XML 32 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2013
Jun. 30, 2013
CURRENT ASSETS:    
Cash and cash equivalents $ 8,603 $ 9,007
Short term bank deposits 24,047 31,449
Restricted cash and restricted short term deposits 753 316
Marketable securities 16,016 13,441
Other current assets 3,049 872
Total current assets 52,468 55,085
LONG-TERM ASSETS:    
Long-term deposits and restricted deposits 311 421
Severance pay fund 1,020 905
Property and equipment, net 11,663 11,866
Other long term assets 21 39
Total long-term assets 13,015 13,231
Total assets 65,483 68,316
CURRENT LIABILITIES    
Trade payables 2,880 2,837
Accrued expenses 1,003 1,040
Deferred revenues 379 379
Advance payment from United Therapeutics 356 393
Other accounts payable 1,113 1,272
Total current liabilities 5,731 5,921
LONG-TERM LIABILITIES    
Deferred revenues 3,131 3,226
Accrued severance pay 1,173 1,023
Other long term liabilities 657 680
Total long term liabilities 4,961 4,929
COMMITMENTS AND CONTINGENCIES      
STOCKHOLDERS' EQUITY    
Common stock $0.00001 par value: Authorized: 100,000,000 shares Issued and outstanding: 59,852,793 shares as of September 30, 2013, 59,196,617 shares as of June 30, 2013      
Additional paid-in capital 145,794 144,109
Accumulated deficit (91,657) (86,902)
Other comprehensive income 654 259
Total stockholders' equity 54,791 57,466
Total liabilities and stockholders' equity $ 65,483 $ 68,316